Join
Live feed
·
PRReleasevia Quantisnow
Aditxt Inc. logo
Evofem Biosciences Inc. logo

Aditxt Subsidiary Pearsanta Completes the Acquisition of Proprietary Adductomics Technology to Develop and Advance the Platform Toward Clinical and Commercial Applications for Monitoring Early Signs of Increased Cancer Risk

ByQuantisnow·Wall Street's wire, on your screen.
ADTX· Aditxt Inc.EVFM· Evofem Biosciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADTX (Aditxt Inc.), EVFM (Evofem Biosciences Inc.) and more on Quantisnow.

Aditxt Subsidiary Pearsanta Completes the Acquisition of Proprietary Adductomics Technology to Develop and Advance the Platform Toward Clinical and Commercial Applications for Monitoring Early Signs of Increased Cancer Risk | Quantisnow